Kiniksa Pharmaceuticals shares are trading higher after Wedbush maintained its Outperform rating on the stock and raised its price target fr
Kiniksa Pharmaceuticals shares are trading higher after Wedbush maintained its Outperform rating on the stock and raised its price target from $59 to $72.
Kiniksa Pharmaceuticals shares are trading higher after Wedbush maintained its Outperform rating on the stock and raised its price target from $59 to $72.